Sri Lanka has been a recipient country of the Global Fund since 2004 and has been disbursed over US$104 million for HIV, TB and malaria.
With the support of a Global Fund supported national strategy using community engagement, effective surveillance and prompt treatment, malaria was eliminated from Sri Lanka in 2012, and the country received WHO-certification in 2016. Global Fund grants in Sri Lanka are currently invested in HIV, TB and RSSH.
Based on projected transitions from Global Fund country allocations by 2028 (March 2021), Sri Lanka was projected to become ineligible in the 2023 – 2025 allocation period based on country move to UMI status and may be eligible for transition funding in 2026 – 2028 for its HIV component. However, it was reclassified as a lower-middle income country by the World Bank in July 2020, and based on the current economic crisis in Sri Lanka and how the calculations are made on its eligibility to receive Global Fund grants based on its GNIpc, it is unclear if Sri Lanka will be eligible for grants in the 2023 – 2025 allocation cycle.
About the action
The action in Sri Lanka is led by Diversity and Solidarity Trust (DAST) with the support of the following partners.